ENFN Enfusion Inc

$10.76

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Enfusion Inc

Enfusion Inc. provides software as a service for the investment management industry in the United States, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Chicago, Illinois.

Website: https://www.enfusion.com

Sector
TECHNOLOGY
Industry
SERVICES-PREPACKAGED SOFTWARE
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1868912
Address
125 SOUTH CLARK STREET, SUITE 750, CHICAGO, IL, US
Valuation
Market Cap
$1.02B
P/E Ratio
358.67
PEG Ratio
nan
Price to Book
13.93
Performance
EPS
$0.03
Dividend Yield
—
Profit Margin
1.40%
ROE
4.42%
Technicals
50D MA
$11.10
200D MA
$9.83
52W High
$11.80
52W Low
$7.83
Fundamentals
Shares Outstanding
95M
Target Price
$11.25
Beta
0.93

ENFN EPS Estimates vs Actual

● Estimated
● Actual

ENFN News & Sentiment

Mar 03, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Enfusion, Inc. ( ENFN ) Lags Q4 Earnings and Revenue Estimates
Enfusion (ENFN) delivered earnings and revenue surprises of -57.14% and 1.94%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Feb 20, 2025 • Benzinga BULLISH
Clearwater Analytics' Enfusion Infusion Offers Compelling Value Proposition, Analyst Upgrades Stock - Clearwater Analytics Hldg ( NYSE:CWAN )
CWAN's Q4 revenue exceeded expectations, posting $126.5 million. Analyst raises price target to $36 based on strong growth potential. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, and real-time market insights.
Feb 19, 2025 • Benzinga SOMEWHAT-BULLISH
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, FNA, LGTY, ACCD on Behalf of Shareholders - Enfusion ( NYSE:ENFN ) , Accolade ( NASDAQ:ACCD )
NEW YORK, Feb. 19, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Enfusion, Inc.
Feb 13, 2025 • Benzinga SOMEWHAT-BULLISH
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IVAC, FNA, LGTY, ENFN on Behalf of Shareholders - Enfusion ( NYSE:ENFN ) , Paragon 28 ( NYSE:FNA )
NEW YORK, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Intevac, Inc.
Feb 13, 2025 • Benzinga SOMEWHAT-BULLISH
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intevac, Inc. ( Nasdaq - IVAC ) , Paragon 28, Inc. ( NYSE - FNA ) , Logility Supply Chain Solutions, Inc. ( Nasdaq - LGTY ) , Enfusion, Inc. ( NYSE - ENFN )
BALA CYNWYD, Pa., Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.
Feb 04, 2025 • Benzinga SOMEWHAT-BULLISH
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LGTY, ENFN, ITCI, SSTK on Behalf of Shareholders - Enfusion ( NYSE:ENFN ) , Intra-Cellular Therapies ( NASDAQ:ITCI )
NEW YORK, Feb. 04, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Logility Supply Chain Solutions, Inc.
Sentiment Snapshot

Average Sentiment Score:

0.086
50 articles with scored sentiment

Overall Sentiment:

Neutral

ENFN Reported Earnings

Mar 10, 2025
Dec 31, 2024 (Pre market)
-0.03 Surprise
  • Reported EPS: $0.03
  • Estimate: $0.06
  • Whisper: —
  • Surprise %: -52.1%
Nov 05, 2024
Sep 30, 2024 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.05
  • Estimate: $0.06
  • Whisper: —
  • Surprise %: -16.7%
Aug 06, 2024
Jun 30, 2024 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.05
  • Estimate: $0.06
  • Whisper: —
  • Surprise %: -16.7%
May 09, 2024
Mar 31, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $0.06
  • Estimate: $0.04
  • Whisper: —
  • Surprise %: 50.0%
Mar 12, 2024
Dec 31, 2023 (Post market)
-0.01 Surprise
  • Reported EPS: $0.04
  • Estimate: $0.05
  • Whisper: —
  • Surprise %: -20.0%
Nov 07, 2023
Sep 30, 2023 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.04
  • Estimate: $0.05
  • Whisper: —
  • Surprise %: -20.0%
Aug 08, 2023
Jun 30, 2023 (Pre market)
0.0 Surprise
  • Reported EPS: $0.04
  • Estimate: $0.04
  • Whisper: —
  • Surprise %: 0.0%
May 09, 2023
Mar 31, 2023 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.02
  • Estimate: $0.03
  • Whisper: —
  • Surprise %: -33.3%
Mar 07, 2023
Dec 31, 2022 (Pre market)
0.01 Surprise
  • Reported EPS: $0.04
  • Estimate: $0.03
  • Whisper: —
  • Surprise %: 33.3%

Financials